Opus Genetics, Inc. · NASDAQ:IRD
Ainsworth Sean received 24,367 Opus Genetics, Inc. shares as an award (Form 4)
Traded Apr 20, 2026 · Filed Apr 22, 2026
On Apr 20, 2026, Ainsworth Sean (Director) received 24,367 Opus Genetics, Inc. shares as an award, leaving 321,692 shares. Filed Apr 22, 2026 (Form 4).
- Awarded
- 24,367 shares
- Holding after
- 321,692 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Award | 24,367 | 321,692 | Direct |
Source
Related
- Opus Genetics, Inc.
- Ainsworth Sean
- Opus Genetics, Inc. shareholders
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026